Drug Database
B01AC27 selexipag
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Uptravi
- POM Uptravi 1000 microgram film-coated tablets (Great Britain)
- POM Uptravi 1200 microgram film-coated tablets (Great Britain)
- POM Uptravi 1400 microgram film-coated tablets (Great Britain)
- POM Uptravi 1600 microgram film-coated tablets (Great Britain)
- POM Uptravi 400 microgram film-coated tablets (Great Britain)
- POM Uptravi 600 microgram film-coated tablets (Great Britain)
- POM Uptravi 800 microgram film-coated tablets (Great Britain)
- POM Uptravi film-coated tablets (Northern Ireland)
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).